Amicus Therapeutics, Inc. (FOLD)
14.34
0.00 (0.00%)
USD |
NASDAQ |
Mar 05, 11:07
Amicus Therapeutics Cash from Investing (Quarterly) : -6.494M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| BioMarin Pharmaceutical, Inc. | -42.45M |
| CorMedix, Inc. | -291.32M |
| Krystal Biotech, Inc. | 11.16M |
| MannKind Corp. | -291.96M |
| Keros Therapeutics, Inc. | -0.132M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 16.25M |
| Cash from Financing (Quarterly) | 14.03M |
| Free Cash Flow | 29.85M |
| Free Cash Flow Per Share (Quarterly) | 0.0508 |
| Free Cash Flow to Equity (Quarterly) | 16.41M |
| Free Cash Flow to Firm (Quarterly) | 22.10M |
| Free Cash Flow Yield | 0.67% |